Lipid tucaresol as an adjuvant for methamphetamine vaccine development

被引：23
|
作者：
Collins, K. C. [1 ,2 ,3 ]
Schlosburg, J. E. [1 ,2 ,3 ,4 ]
Lockner, J. W. [1 ,2 ,3 ]
Bremer, P. T. [1 ,2 ,3 ]
Ellis, B. A. [1 ,2 ,3 ]
Janda, K. D. [1 ,2 ,3 ]
机构：
[1] Scripps Res Inst, Dept Chem, Skaggs Inst Chem Biol, WIRM, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Immunol, Skaggs Inst Chem Biol, WIRM, La Jolla, CA 92037 USA
[3] Scripps Res Inst, Dept Microbial Sci, Skaggs Inst Chem Biol, WIRM, La Jolla, CA 92037 USA
[4] Scripps Res Inst, Comm Neurobiol Addict Disorders, La Jolla, CA 92037 USA
来源：
CHEMICAL COMMUNICATIONS | 2014年 / 50卷 / 31期
关键词：
IMMUNIZATION; LIPOSOMES; HAPTEN; SYSTEM; IMPACT;
D O I：
10.1039/c4cc00682h
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
The immunopotentiator tucaresol was modified for incorporation into liposomes, where it was found to be a superior adjuvant to MPLA for vaccination against methamphetamine.
引用
收藏
页码：4079 / 4081
页数：3
相关论文
共 50 条
  • [1] Development and characterization of a novel conjugated methamphetamine vaccine
    Hossain, Md Kamal
    Davidson, Majid
    Feehan, Jack
    Deraos, George
    Nurgali, Kulmira
    Matsoukas, John
    Apostolopoulos, Vasso
    VACCINE, 2022, 40 (41) : 5882 - 5891
  • [2] Vaccine development against methamphetamine drug addiction
    Hossain, Md Kamal
    Hassanzadeganroudsari, Majid
    Nurgali, Kulmira
    Apostolopoulos, Vasso
    EXPERT REVIEW OF VACCINES, 2020, 19 (12) : 1105 - 1114
  • [3] Archaeal lipid mucosal vaccine adjuvant and delivery system
    Patel, Girishchandra B.
    Chen, Wangxue
    EXPERT REVIEW OF VACCINES, 2010, 9 (04) : 431 - 440
  • [4] A novel adjuvant for vaccine development in the aged
    Morgan, Edward L.
    Thoman, Marilyn L.
    Sanderson, Sam D.
    Phillips, Joy A.
    VACCINE, 2010, 28 (52) : 8275 - 8279
  • [5] Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine
    Patil, Harshad P.
    Murugappan, Senthil
    ter Veer, Wouter
    Meijerhof, Tjarko
    de Haana, Aalzen
    Frijlink, Henderik W.
    Wilschut, Jan
    Hinrichs, Wouter L. J.
    Huckriede, Anke
    JOURNAL OF CONTROLLED RELEASE, 2014, 174 : 51 - 62
  • [6] Flagellin as Carrier and Adjuvant in Cocaine Vaccine Development
    Lockner, Jonathan W.
    Eubanks, Lisa M.
    Choi, Jennifer L.
    Lively, Jenny M.
    Schlosburg, Joel E.
    Collins, Karen C.
    Globisch, Daniel
    Rosenfeld-Gunn, Robin J.
    Wilson, Ian A.
    Janda, Kim D.
    MOLECULAR PHARMACEUTICS, 2015, 12 (02) : 653 - 662
  • [7] Topical resiquimod: a promising adjuvant for vaccine development?
    Igartua, Manoli
    Luis Pedraz, Jose
    EXPERT REVIEW OF VACCINES, 2010, 9 (01) : 23 - 27
  • [8] Engineering Escherichia coli for constitutive production of monophosphoryl lipid A vaccine adjuvant
    Jin, Hyunjung
    Ji, Yuhyun
    An, Jinsu
    Ha, Da Hui
    Lee, Ye-Ram
    Kim, Hye-Ji
    Lee, Choon Geun
    Jeong, Wooyeon
    Kwon, Ick Chan
    Yang, Eun Gyeong
    Kim, Ki Hun
    Lee, Chankyu
    Chung, Hak Suk
    BIOTECHNOLOGY AND BIOENGINEERING, 2024, 121 (03) : 1144 - 1162
  • [9] Nanoparticle Based Tailoring of Adjuvant Function: The Role in Vaccine Development
    Prashant, Chandravilas Keshvan
    Kumar, Manoj
    Dinda, Amit Kumar
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2014, 10 (09) : 2317 - 2331
  • [10] Development of novel cationic microemulsion as parenteral adjuvant for influenza vaccine
    Lamaisakul, Sakalanunt
    Tantituvanont, Angkana
    Lipipun, Vimolmas
    Ritthidej, Garnpimol
    ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 15 (05) : 591 - 604
12345